Old Web
English
Sign In
Acemap
>
authorDetail
>
Siegfried Roesch
Siegfried Roesch
Modified vaccinia Ankara
Immunogenicity
Vaccination
Virology
Immunology
3
Papers
146
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects.
2016
PLOS ONE
Richard N. Greenberg
Christine M. Hay
Jack T. Stapleton
Thomas C. Marbury
Eva Wagner
Eva Kreitmeir
Siegfried Roesch
Alfred von Krempelhuber
Philip Young
Richard A. Nichols
Thomas Peter Meyer
Darja Schmidt
Josef Weigl
Garth Virgin
Nathaly Arndtz-Wiedemann
Paul Chaplin
Show All
Source
Cite
Save
Citations (27)
A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18-40 Year Old Subjects with Diagnosed Atopic Dermatitis
2015
PLOS ONE
Richard N. Greenberg
Yadira Hurley
Dinh V. Dinh
Serena Mraz
Javier Gómez Vera
Dorothea von Bredow
Alfred von Krempelhuber
Siegfried Roesch
Garth Virgin
Nathaly Arndtz-Wiedemann
Thomas Peter Meyer
Darja Schmidt
Richard A. Nichols
Philip Young
Paul Chaplin
Show All
Source
Cite
Save
Citations (98)
Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis
2014
Vaccine
Frank von Sonnenburg
Pamela Perona
Ulf Darsow
Johannes Ring
Alfred von Krempelhuber
Jens Vollmar
Siegfried Roesch
Nicole Baedeker
Herwig Kollaritsch
Paul Chaplin
Show All
Source
Cite
Save
Citations (21)
1